Evaluation of S/F94 as a proxy for COVID-19 severity

Maaike C Swets, Steven Kerr, James Scott-Brown, Adam B Brown, Rishi Gupta, Jonathan E Millar, Enti Spata, Fiona McCurrach, Andrew D Bretherick, Annemarie Docherty, David Harrison, Kathy Rowan, Neil Young, ISARIC4C Investigators, Geert H Groeneveld, Jake Dunning, Jonathan S Nguyen-Van-Tam, Peter Openshaw, Peter W. Horby, Ewen Harrison, Natalie Staplin, Malcolm G Semple, Nazir Lone, J Kenneth Baillie
doi: https://doi.org/10.1101/2022.09.25.22280081

Data Availability

The dataset used and analysed in this study is not available, but a synthetically generated dataset, containing the same key properties as the original dataset is available for sample size calculations on https://isaric4c.net/endpoints

https://isaric4c.net/endpoints

Back to top
Posted September 27, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Evaluation of S/F94 as a proxy for COVID-19 severity
Maaike C Swets, Steven Kerr, James Scott-Brown, Adam B Brown, Rishi Gupta, Jonathan E Millar, Enti Spata, Fiona McCurrach, Andrew D Bretherick, Annemarie Docherty, David Harrison, Kathy Rowan, Neil Young, ISARIC4C Investigators, Geert H Groeneveld, Jake Dunning, Jonathan S Nguyen-Van-Tam, Peter Openshaw, Peter W. Horby, Ewen Harrison, Natalie Staplin, Malcolm G Semple, Nazir Lone, J Kenneth Baillie
medRxiv 2022.09.25.22280081; doi: https://doi.org/10.1101/2022.09.25.22280081
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area